News Briefs: GE Healthcare Buys Thermo Fisher Research Tools; BD Acquires Alverix
This article was originally published in The Gray Sheet
Executive Summary
GE Healthcare purchased Thermo Fisher’s research tools for $1 billion. Becton Dickinson acquires point-of-care diagnostic maker Alverix for $40 million. More news briefs.
You may also be interested in...
Spine Market: Pure Plays Continue to Grab Share
Amidst low growth and a potential rebound in the $9 billion global spine market, the pure-play spine companies, including NuVasive, Globus, K2M and LDR, continue to outperform and grab share from the diversified giants. Medtech Insight founder and former CEO Sharon O'Reilly reports on these companies and more from the 2015 North American Spine Society (NASS) conference in Chicago, where the latest news centered around ancillary approaches to fusion, patient-specific tools, robotics, biologics, expandable cages, MIS and cervical discs.
Stryker MAKO Purchase Could Preview Ortho’s Future
Market-leading orthopedic firms have mostly come up with incremental product updates in response to the growing tide of more technology-heavy upstarts. That is what makes Stryker’s $1.65 billion acquisition of MAKO Surgical stand out.
Life Technologies Extends Thermo Fisher’s Reach Into Clinical Practice
Thermo Fisher’s $13.6 billion bid for Life Technologies is a blockbuster move within the instrumentation and consumables space, and also has implications for clinical practice. It’s another sign of the growing recognition that integrating clinical workflow is an important potential area for innovation and growth, along with the desire to move genomics tools into clinical use and the development of test content by nontraditional players in diagnostics.